{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:50:04Z","timestamp":1790599804416,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00535-022-01886-4","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T14:02:56Z","timestamp":1655301776000},"page":"529-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"57","author":[{"given":"Andrea","family":"Mulliri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Menahem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7858-0581","authenticated-orcid":false,"given":"Beno\u00eet","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"issue":"Suppl 3","key":"1886_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.0953-0673.2003.01721.x","volume":"18","author":"R Aerts","year":"2003","unstructured":"Aerts R, Penninckx F. The burden of gallstone disease in Europe. Aliment Pharmacol Ther. 2003;18(Suppl 3):49\u201353.","journal-title":"Aliment Pharmacol Ther"},{"key":"1886_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/ajcn\/55.3.652","volume":"55","author":"MJ Stampfer","year":"1992","unstructured":"Stampfer MJ, Maclure KM, Colditz GA, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652\u20138.","journal-title":"Am J Clin Nutr"},{"key":"1886_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIR.0b013e318282ab8f","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics\u20132013 update: a report from the American Heart Association. Circulation. 2013;127:143\u201352.","journal-title":"Circulation"},{"key":"1886_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/j.1550-8528.1993.tb00008.x","volume":"1","author":"RL Weinsier","year":"1993","unstructured":"Weinsier RL, Ullmann DO. Gallstone formation and weight loss. Obes Res. 1993;1:51\u20136.","journal-title":"Obes Res"},{"key":"1886_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/BF01300390","volume":"37","author":"H Yang","year":"1992","unstructured":"Yang H, Petersen GM, Roth MP, et al. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci. 1992;37:912\u20138.","journal-title":"Dig Dis Sci"},{"key":"1886_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0002-9610(99)80115-9","volume":"169","author":"HJ Sugerman","year":"1995","unstructured":"Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169:91\u20136.","journal-title":"Am J Surg"},{"key":"1886_CR7","first-page":"1705","volume":"88","author":"LJ Worobetz","year":"1993","unstructured":"Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88:1705\u201310.","journal-title":"Am J Gastroenterol"},{"key":"1886_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11695-011-0575-y","volume":"22","author":"M Worni","year":"2012","unstructured":"Worni M, Guller U, Shah A, et al. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg. 2012;22:220\u20139.","journal-title":"Obes Surg"},{"key":"1886_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.soard.2019.03.028","volume":"15","author":"TM Nabil","year":"2019","unstructured":"Nabil TM, Khalil AH, Gamal K. Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity. Surg Obes Relat Dis. 2019;15:827\u201331.","journal-title":"Surg Obes Relat Dis"},{"key":"1886_CR10","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1007\/s11695-020-04801-z","volume":"30","author":"F Pizza","year":"2020","unstructured":"Pizza F, D\u2019Antonio D, Lucido FS, et al. The role of Ursodeoxycholic acid (UDCA) in Cholelithiasis management after One Anastomosis Gastric Bypass (OAGB) for morbid obesity: results of a monocentric randomized controlled trial. Obes Surg. 2020;30:4315\u201324.","journal-title":"Obes Surg"},{"key":"1886_CR11","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s13304-020-00850-2","volume":"72","author":"N Sakran","year":"2020","unstructured":"Sakran N, Dar R, Assalia A, et al. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial. Updates Surg. 2020;72:1125\u201333.","journal-title":"Updates Surg"},{"key":"1886_CR12","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1007\/s00464-019-07323-7","volume":"34","author":"A Talha","year":"2020","unstructured":"Talha A, Abdelbaki T, Farouk A, et al. Cholelithiasis after bariatric surgery, incidence, and prophylaxis: randomized controlled trial. Surg Endosc. 2020;34:5331\u20137.","journal-title":"Surg Endosc"},{"key":"1886_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1381\/096089293765559278","volume":"3","author":"C Williams","year":"1993","unstructured":"Williams C, Gowan R, Perey BJ. A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical banded gastroplasty. Obes Surg. 1993;3:257\u20139.","journal-title":"Obes Surg"},{"key":"1886_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/jsre.2001.6322","volume":"102","author":"LJ Wudel Jr","year":"2002","unstructured":"Wudel LJ Jr, Wright JK, Debelak JP, et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002;102:50\u20136.","journal-title":"J Surg Res"},{"key":"1886_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jhbp.946","volume":"28","author":"JH Choi","year":"2021","unstructured":"Choi JH, Lee SH, Cho IR, et al. Ursodeoxycholic acid for the prevention of gallstone and subsequent cholecystectomy following gastric surgery: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci. 2021;28:409\u201318.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1886_CR16","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1007\/s11695-017-2924-y","volume":"27","author":"DE Magouliotis","year":"2017","unstructured":"Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: an updated systematic review and meta-analysis. Obes Surg. 2017;27:3021\u201330.","journal-title":"Obes Surg"},{"key":"1886_CR17","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.cgh.2013.11.031","volume":"12","author":"CS Stokes","year":"2014","unstructured":"Stokes CS, Gluud LL, Casper M, et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2014;12:1090\u2013100.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1886_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.soard.2021.10.004","volume":"18","author":"NM Fearon","year":"2022","unstructured":"Fearon NM, Kearns EC, Kennedy CA, et al. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials. Surg Obes Relat Dis. 2022;18:77\u201384.","journal-title":"Surg Obes Relat Dis"},{"key":"1886_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S2468-1253(21)00301-0","volume":"6","author":"S Haal","year":"2021","unstructured":"Haal S, Guman MSS, Boerlage TCC, et al. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial. Lancet Gastroenterol Hepatol. 2021;6:993\u20131001.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1886_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-021-08980-3","author":"MA Salman","year":"2022","unstructured":"Salman MA, Salman A, Mohamed US, et al. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study. Surg Endosc. 2022. https:\/\/doi.org\/10.1007\/s00464-021-08980-3.","journal-title":"Surg Endosc"},{"key":"1886_CR21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"1886_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00595-016-1446-x","volume":"47","author":"E Abdallah","year":"2017","unstructured":"Abdallah E, Emile SH, Elfeki H, et al. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy. Surg Today. 2017;47:844\u201350.","journal-title":"Surg Today"},{"key":"1886_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/00015458.2020.1857569","volume":"121","author":"M Alimogullari","year":"2021","unstructured":"Alimogullari M, Bulus H. Effectiveness of ursodeoxycholic acid treatment in the prevention of gallstone formation after laparoscopic sleeve gastrectomy. Acta Chir Belg. 2021;121:109\u201314.","journal-title":"Acta Chir Belg"},{"key":"1886_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.soard.2016.11.022","volume":"13","author":"M Coupaye","year":"2017","unstructured":"Coupaye M, Calabrese D, Sami O, et al. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surg Obes Relat Dis. 2017;13:681\u20135.","journal-title":"Surg Obes Relat Dis"},{"key":"1886_CR26","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1007\/s11695-019-03862-z","volume":"29","author":"M Coupaye","year":"2019","unstructured":"Coupaye M, Calabrese D, Sami O, et al. Effectiveness of ursodeoxycholic acid in the prevention of cholelithiasis after sleeve gastrectomy. Obes Surg. 2019;29:2464\u20139.","journal-title":"Obes Surg"},{"key":"1886_CR27","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1007\/s11695-018-03651-0","volume":"29","author":"A Della Penna","year":"2019","unstructured":"Della Penna A, Lange J, Hilbert J, et al. Ursodeoxycholic acid for 6\u00a0months after bariatric surgery is impacting gallstone associated morbidity in patients with preoperative asymptomatic gallstones. Obes Surg. 2019;29:1216\u201321.","journal-title":"Obes Surg"},{"key":"1886_CR28","doi-asserted-by":"publisher","first-page":"e20190010000009","DOI":"10.1590\/s0102-865020190010000009","volume":"34","author":"FHF Machado","year":"2019","unstructured":"Machado FHF, Castro Filho HF, Babadopulos R, et al. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1. Acta Cir Bras. 2019;34:e20190010000009.","journal-title":"Acta Cir Bras"},{"key":"1886_CR29","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1089\/lap.2020.0077","volume":"30","author":"O Sen","year":"2020","unstructured":"Sen O, Turkcapar AG, Yerdel MA. Cholelithiasis after sleeve gastrectomy and effectiveness of ursodeoxycholic acid treatment. J Laparoendosc Adv Surg Tech A. 2020;30:1150\u20132.","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"1886_CR30","first-page":"33","volume":"83","author":"A Vural","year":"2020","unstructured":"Vural A, Goksu K, Kahraman AN, et al. Increased gallstone formation after sleeve gastrectomy and the preventive role of ursodeoxycholic acid. Acta Gastroenterol Belg. 2020;83:33\u20138.","journal-title":"Acta Gastroenterol Belg"},{"key":"1886_CR31","first-page":"666","volume":"15","author":"M Ul Hassan","year":"2021","unstructured":"Ul Hassan M, Akram MA, Javaid I, et al. Role of ursodeoxycholic acid in prevention of gallstones after sleeve gastrectomy. Pak J Med Health Sci. 2021;15:666\u20138.","journal-title":"Pak J Med Health Sci"},{"key":"1886_CR32","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s11695-015-1858-5","volume":"26","author":"LB Adams","year":"2016","unstructured":"Adams LB, Chang C, Pope J, et al. Randomized, prospective comparison of ursodeoxycholic acid for the prevention of gallstones after sleeve gastrectomy. Obes Surg. 2016;26:990\u20134.","journal-title":"Obes Surg"},{"key":"1886_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/01.sla.0000094305.77843.cf","volume":"238","author":"K Miller","year":"2003","unstructured":"Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238:697\u2013702.","journal-title":"Ann Surg"},{"key":"1886_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/ejs.ejs_29_18","volume":"37","author":"TAO Abouzeid","year":"2018","unstructured":"Abouzeid TAO, Shoka AAA. Should we prescribe ursodeoxycholic acid after laparoscopic sleeve gastrectomy? A two-center prospective randomized controlled trial. Egypt J Surg. 2018;37:349\u201354.","journal-title":"Egypt J Surg"},{"key":"1886_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-9343(99)80394-5","volume":"98","author":"RL Weinsier","year":"1995","unstructured":"Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med. 1995;98:115\u20137.","journal-title":"Am J Med"},{"key":"1886_CR36","doi-asserted-by":"publisher","first-page":"e1001925","DOI":"10.1371\/journal.pmed.1001925","volume":"12","author":"IJ Douglas","year":"2015","unstructured":"Douglas IJ, Bhaskaran K, Batterham RL, et al. Bariatric surgery in the United Kingdom: a cohort study of weight loss and clinical outcomes in routine clinical care. PLoS Med. 2015;12:e1001925.","journal-title":"PLoS Med"},{"key":"1886_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0016-5085(99)70456-7","volume":"117","author":"JE Everhart","year":"1999","unstructured":"Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117:632\u20139.","journal-title":"Gastroenterology"},{"key":"1886_CR38","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/MEG.0b013e32834b0e0e","volume":"23","author":"S Hong","year":"2011","unstructured":"Hong S, Qiwen B, Ying J, et al. Body mass index and the risk and prognosis of acute pancreatitis: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23:1136\u201343.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1886_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s11695-019-04366-6","volume":"30","author":"MA Sneineh","year":"2020","unstructured":"Sneineh MA, Harel L, Elnasasra A, et al. Increased incidence of symptomatic cholelithiasis after bariatric roux-En-Y gastric bypass and previous bariatric surgery: a single center experience. Obes Surg. 2020;30:846\u201350.","journal-title":"Obes Surg"},{"key":"1886_CR40","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.soard.2020.05.025","volume":"16","author":"A Anveden","year":"2020","unstructured":"Anveden A, Peltonen M, Naslund I, et al. Long-term incidence of gallstone disease after bariatric surgery: results from the nonrandomized controlled Swedish Obese Subjects study. Surg Obes Relat Dis. 2020;16:1474\u201382.","journal-title":"Surg Obes Relat Dis"},{"key":"1886_CR41","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s11695-022-05947-8","volume":"32","author":"S Haal","year":"2022","unstructured":"Haal S, Guman MSS, Bruin S, et al. Risk factors for symptomatic gallstone disease and gallstone formation after bariatric surgery. Obes Surg. 2022;32:1270\u20138.","journal-title":"Obes Surg"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-022-01886-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-022-01886-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-022-01886-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T16:04:06Z","timestamp":1658592246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-022-01886-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1007\/s00535-022-01886-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}